Combined pre- and postsynaptic action of IgG antibodies in Miller Fisher syndrome

被引:54
作者
Buchwald, B
Bufler, J
Carpo, M
Heidenreich, F
Pitz, R
Dudel, J
Nobile-Orazio, E
Toyka, KV
机构
[1] Univ Wurzburg, Neurol Klin, D-97080 Wurzburg, Germany
[2] Tech Univ Munich, Neurol Klin, D-8000 Munich, Germany
[3] Univ Milan, Ctr Dino Ferrari, Inst Clin Neurol, Giorgio Spagnol Lab Clin Neuroimmunol, Milan, Italy
[4] Hannover Med Sch, Neurol Klin, Hannover, Germany
[5] Tech Univ Munich, Inst Physiol, D-8000 Munich, Germany
关键词
D O I
10.1212/WNL.56.1.67
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Miller Fisher syndrome (MFS), a variant of the Guillain-Barre syndrome, is associated with the presence of neuromuscular blocking antibodies, some of which may be directed at the ganglioside GQ1b. Materials and Methods: The authors investigated the in vitro effects of serum and purified immunoglobulin (Ig) G in a total of 11 patients with typical MFS during active disease, and in three of those patients after recovery. From one patient's serum, we prepared an IgG fraction enriched in anti-GQ1b antibodies by affinity chromatography. For combined pre- and postsynaptic analysis, endplate currents were recorded by a perfused macro-patch clamp electrode. Postsynaptic nicotinic acetylcholine receptor channels were investigated by an outside-out patch clamp technique in cultured mouse myotubes. Results: All MFS-sera depressed evoked quantal release and reduced the amplitude of postsynaptic currents. Five of the II sera were additionally examined by outside-out patch clamp analysis and caused a concentration-dependent and reversible decrease in acetylcholine-induced currents. The time course of activation and desensitization of nicotinic acetylcholine receptor channels was not altered by MFS-IgG. Nine patients (82%) were positive for anti-GQ1b antibodies in ELISA and dot-blot. The enriched anti-GQ1b antibody fraction had a similar effect as whole serum. After recovery from MFS, blocking activity was lost and sera originally positive for anti-GQ1b antibodies became negative. Conclusion: Circulating IgG antibodies induce both pre- and postsynaptic blockade and may play a pathogenic role in acute MFS.
引用
收藏
页码:67 / 74
页数:8
相关论文
共 48 条
[1]   MYASTHENIA-GRAVIS - LONG-TERM CORRELATION OF BINDING AND BUNGAROTOXIN BLOCKING ANTIBODIES AGAINST ACETYLCHOLINE-RECEPTORS WITH CHANGES IN DISEASE SEVERITY [J].
BESINGER, UA ;
TOYKA, KV ;
HOMBERG, M ;
HEININGER, K ;
HOHLFELD, R ;
FATEHMOGHADAM, A .
NEUROLOGY, 1983, 33 (10) :1316-1321
[2]   THE NOT-SO-BENIGN MILLER FISHER SYNDROME - A VARIANT OF THE GUILLAIN-BARRE-SYNDROME [J].
BLAU, I ;
CASSON, I ;
LIEBERMAN, A ;
WEISS, E .
ARCHIVES OF NEUROLOGY, 1980, 37 (06) :384-385
[3]   Neuromuscular blockade by IgG antibodies from patients with Guillain-Barre syndrome: A macro-patch-clamp study [J].
Buchwald, B ;
Toyka, KV ;
Zielasek, J ;
Weishaupt, A ;
Schweiger, S ;
Dudel, J .
ANNALS OF NEUROLOGY, 1998, 44 (06) :913-922
[4]   Pre-and postsynaptic blockade of neuromuscular transmission by Miller-Fisher syndrome IgG at mouse motor nerve terminals [J].
Buchwald, B ;
Weishaupt, A ;
Toyka, KV ;
Dudel, J .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1998, 10 (01) :281-290
[5]   Immunoglobulin G from a patient with Miller-Fisher syndrome rapidly and reversibly depresses evoked quantal release at the neuromuscular junction of mice [J].
Buchwald, B ;
Weishaupt, A ;
Toyka, KV ;
Dudel, J .
NEUROSCIENCE LETTERS, 1995, 201 (02) :163-166
[6]   Activation and blockade of mouse muscle nicotinic channels by antibodies directed against the binding site of the acetylcholine receptor [J].
Bufler, J ;
Kahlert, S ;
Tzartos, S ;
Toyka, KV ;
Maelicke, A ;
Franke, C .
JOURNAL OF PHYSIOLOGY-LONDON, 1996, 492 (01) :107-114
[7]   Open channel block by physostigmine and procaine in embryonic-like nicotinic receptors of mouse muscle [J].
Bufler, J ;
Franke, C ;
Parnas, H ;
Dudel, J .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1996, 8 (04) :677-687
[8]   Purified IgG from seropositive and seronegative patients with myasthenia gravis reversibly blocks currents through nicotinic acetylcholine receptor channels [J].
Bufler, J ;
Pitz, R ;
Czep, M ;
Wick, M ;
Franke, C .
ANNALS OF NEUROLOGY, 1998, 43 (04) :458-464
[9]  
BUFLER J, 1996, J PHYSL, V95, P83
[10]   Clinical correlate and fine specificity of anti-GQ1b antibodies in peripheral neuropathy [J].
Carpo, M ;
Pedotti, R ;
Lolli, F ;
Pitrola, A ;
Allaria, S ;
Scarlato, G ;
Nobile-Orazio, E .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1998, 155 (02) :186-191